Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
J Ethnopharmacol ; 317: 116783, 2023 Dec 05.
Artículo en Inglés | MEDLINE | ID: mdl-37321428

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: While the antimicrobial activity of a number of plants used in traditional Mayan medicine against infectious diseases has been documented, their potential to inhibit quorum sensing (QS) as means of discovering novel anti-virulence agents remains unexplored. AIM OF THE STUDY: To evaluate the anti-virulence potential of plants used in traditional Mayan medicine by determining their inhibition of QS- regulated virulence factors in Pseudomonas aeruginosa. METHODS: A group of plants used in traditional Mayan medicine against infectious diseases was selected, and their methanolic extracts were evaluated at 10 mg/mL for their antibacterial and anti-virulence activity using the reference strain P. aeruginosa PA14WT. The broth microdilution method was used to determine antibacterial activity (MIC), while anti-virulence activity was evaluated by measuring the anti-biofilm effect and the inhibition of pyocyanin and protease activities. The most bioactive extract was fractionated using a liquid-liquid partition procedure and the semipurified fractions were evaluated at 5 mg/mL for antibacterial and anti-virulence activity. RESULTS: Seventeen Mayan medicinal plants traditionally used to treat infection-associated diseases were selected. None of the extracts exhibited antibacterial activity, whereas anti-virulence activity was detected in extracts of Bonellia flammea, Bursera simaruba, Capraria biflora, Ceiba aesculifolia, Cissampelos pareira and Colubrina yucatanensis. The most active extracts (74% and 69% inhibition) against biofilm formation were from C. aesculifolia (bark) and C. yucatanensis (root), respectively. Alternatively, the extracts of B. flammea (root), B. simaruba (bark), C. pareira (root), and C. biflora (root), reduced pyocyanin and protease production (50-84% and 30-58%, respectively). Fractionation of the bioactive root extract of C. yucatanensis allowed the identification of two semipurified fractions with anti-virulence activity. CONCLUSIONS: The anti-virulence activity detected in the crude extracts of B. flammea, B. simaruba, C. biflora, C. aesculifolia, C. pareira, and C. yucatanensis, confirms the efficacy and traditional use of these medicinal plants against infectious diseases. The activity of the extract and semipurified fractions of C. yucatanensis indicates the presence of hydrophilic metabolites capable of interfering with QS in P. aeruginosa. This study represents the first report of Mayan medicinal plants with anti-QS properties and suggests they represent an important source of novel anti-virulence agents.


Asunto(s)
Infecciones Bacterianas , Enfermedades Transmisibles , Plantas Medicinales , Piocianina/metabolismo , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Percepción de Quorum , Biopelículas , Plantas Medicinales/metabolismo , Antibacterianos/farmacología , Factores de Virulencia , Péptido Hidrolasas , Pseudomonas aeruginosa
2.
Biomed Pharmacother ; 162: 114579, 2023 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-36989714

RESUMEN

Raphanus sativus L. (Brassicaceae), commonly known as radish, is consumed worldwide as a vegetable. However, its benefits on mental health are unknown. The aim of this study was to evaluate its anxiolytic-like effects and safety using different experimental models. An aqueous extract of R. sativus sprouts (AERSS) was pharmacologically evaluated by intraperitoneal route (i.p.) at 10, 30, and 100 mg/kg and orally (p.o.) at 500 mg/kg on behavior by using open-field and plus-maze tests. In addition, its acute toxicity (LD50) was determined by the Lorke's method. Diazepam (1 mg/kg, i.p.) and buspirone (4 mg/kg, i.p.) were the reference drugs. A significant and anxiolytic-like dosage of AERSS (30 mg/kg, i.p.) resembling the effects of reference drugs was chosen to explore the involvement of GABAA/BDZs site (flumazenil, 5 mg/kg, i.p.) and serotonin 5-HT1A receptors (WAY100635, 1 mg/kg, i.p.) as a possible mechanism of action. A 500 mg/kg, p.o. dosage of AERSS produced an anxiolytic-like response equivalent to 100 mg/kg, i.p. No acute toxicity was observed since a LD50 > 2000 mg/kg, i.p. The phytochemical analysis allowed the identification and quantification of major presence of sulforaphene (2500 µM), sulforaphane (15 µM), iberin (0.75 µM), and indol-3-carbinol (0.75 µM), as major constituents. Both the GABAA/BDZs site and serotonin 5-HT1A receptors were involved in the anxiolytic-like activity of AERSS, depending on the pharmacological parameter or the experimental assay tested. Our results demonstrate that the anxiolytic activity of R. sativus sprouts involves GABAA/BDZs site and serotonin 5-HT1A receptors supporting its health benefits in the treatment of anxiety beyond the satisfaction of basic nutritional needs.


Asunto(s)
Ansiolíticos , Raphanus , Ratones , Animales , Ansiolíticos/farmacología , Serotonina/farmacología , Diazepam/farmacología , Ansiedad/tratamiento farmacológico , Agua/farmacología , Ácido gamma-Aminobutírico/farmacología , Conducta Animal
3.
Microorganisms ; 9(12)2021 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-34946027

RESUMEN

Several plant extracts exhibit anti-virulence properties due to the interruption of bacterial quorum sensing (QS). However, studies on their effects at the preclinical level are scarce. Here, we used a murine model of abscess/necrosis induced by Pseudomonas aeruginosa to evaluate the anti-pathogenic efficacy of 24 plant extracts at a sub-inhibitory concentration. We analyzed their ability to inhibit QS-regulated virulence factors such as swarming, pyocyanin production, and secretion of the ExoU toxin via the type III secretion system (T3SS). Five of the seven extracts with the best anti-pathogenic activity reduced ExoU secretion, and the extracts of Diphysa americana and Hibiscus sabdariffa were identified as the most active. Therefore, the abscess/necrosis model allows identification of plant extracts that have the capacity to reduce pathogenicity of P. aeruginosa. Furthermore, we evaluated the activity of the plant extracts on Chromobacterium violaceum. T3SS (ΔescU) and QS (ΔcviI) mutant strains were assessed in both the abscess/necrosis and sepsis models. Only the ΔescU strain had lower pathogenicity in the animal models, although no activity of plant extracts was observed. These results demonstrate differences between the anti-virulence activity recorded in vitro and pathogenicity in vivo and between the roles of QS and T3S systems as virulence determinants.

4.
J Med Food ; 24(9): 934-943, 2021 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-33751918

RESUMEN

Hibiscus sabdariffa L. (Hs) calyxes, rich in organic acids, are included in diets in different countries. In recent years, some phytochemicals have been shown to reduce bacterial virulence at sublethal concentrations by interfering with quorum sensing (QS) systems. Therefore, in this study the antivirulence properties of Hs calyxes and two γ-lactones (hibiscus acid [HA] and its methyl ester) in Pseudomonas aeruginosa were analyzed. Acetone and methanol extracts of Hs showed anti-QS activity by inhibiting violacein production (60% to 80% with 250 µg/mL). In molecular docking analysis, the γ-lactones registered a good binding score, which suggests strong interaction with the active site of LasR protein. To verify their effect in vitro, they were isolated from Hs and evaluated in six QS-regulated phenotypes, as well as in ExoU toxin that is released by the type III secretion system (T3SS). At 500 µg/mL they reduced alkaline protease (29-52%) and elastase (15-37%) activity, biofilm formation (∼75%), and swarming (50%), but there was no effect on pyocyanin production, hemolytic activity, or type III secretion. In a mouse abscess/necrosis model, HA at sublethal concentrations (15 and 31.2 µg/mL) affected infection establishment and prevented damage and systemic spread. In conclusion, HA is the first molecule identified with antivirulence properties in Hs with the potential to prevent infections caused by P. aeruginosa.


Asunto(s)
Hibiscus , Pseudomonas aeruginosa , Animales , Antibacterianos , Biopelículas , Citratos , Ratones , Simulación del Acoplamiento Molecular , Fitoquímicos , Virulencia
5.
J Med Food ; 21(4): 356-363, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29172966

RESUMEN

Seed oils from oleaginous plants are rich in fatty acids (FAs) that play important roles in the health of the consumers. Recent studies indicate that FA also can play an important role in communication and regulation of virulence in bacteria. Nevertheless, evidence demonstrating protection against bacterial infections mediated by their quorum sensing inhibition (QSI) activity is scarce. In this study, sunflower, chia, and amaranth oils, were assayed for their QSI capacity by inhibiting violacein production and alkaline exoprotease activity of Chromobacterium violaceum. In vitro assays revealed that the oils exhibited QSI activities, whereas in vivo they delayed death of mice inoculated intraperitoneally with the bacterium. Gas chromatography coupled with mass spectrometry analysis of the oils indicated the presence of saturated FA (SAFA) and unsaturated FA as main components. Through a structure-activity relationship study of free FAs, bactericidal effect was identified mainly for polyunsaturated FAs, whereas QSI activity was restricted to SAFA of chains 12-18 carbon atoms in length. These data correlate with a possible interaction suggested by molecular docking analysis of lauric, myristic, and stearic acids with the CviR protein. Our study highlights the antiquorum sensing potential of SAFA, which may be future antivirulence therapeutic agents for the treatment of bacterial infections.


Asunto(s)
Antibacterianos/farmacología , Chromobacterium/efectos de los fármacos , Ácidos Grasos/farmacología , Magnoliopsida/química , Aceites de Plantas/farmacología , Percepción de Quorum/efectos de los fármacos , Semillas/química , Amaranthus/química , Animales , Antibacterianos/química , Antibacterianos/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/microbiología , Chromobacterium/metabolismo , Chromobacterium/patogenicidad , Exopeptidasas/metabolismo , Ácidos Grasos/química , Ácidos Grasos/uso terapéutico , Ácidos Grasos Insaturados/química , Ácidos Grasos Insaturados/farmacología , Ácidos Grasos Insaturados/uso terapéutico , Cromatografía de Gases y Espectrometría de Masas , Helianthus/química , Indoles/metabolismo , Ratones , Simulación del Acoplamiento Molecular , Aceites de Plantas/química , Aceites de Plantas/uso terapéutico , Salvia/química , Relación Estructura-Actividad , Factores de Virulencia/metabolismo
6.
Curr Top Med Chem ; 17(10): 1157-1176, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27697046

RESUMEN

Despite the fact that bacterial infections are one of the leading causes of death worldwide and that mortality rates are increasing at alarming rates, no new antibiotics have been produced by the pharmaceutical industry in more than a decade. The situation is so dire that the World Health Organization warned that we may enter a "post-antibiotic era" within this century; accordingly, bacteria resistant against all known antibiotics are becoming common and already producing untreatable infections. Although several novel approaches to combat bacterial infections have been proposed, they have yet to be implemented in clinical practice. Hence, we propose that a more plausible and faster approach is the utilization of drugs originally developed for other purposes besides antimicrobial activity. Among these are some anticancer molecules proven effective in vitro for eliminating recalcitrant, multidrug tolerant bacteria; some of which also protect animals from infections and recently are undergoing clinical trials. In this review, we highlight the similarities between cancer cells/tumors and bacterial infections, and present evidence that supports the utilization of some anticancer drugs, including 5-fluorouracil (5-FU), gallium (Ga) compounds, and mitomycin C, as antibacterials. Each of these drugs has some promising properties such as broad activity (all three compounds), dual antibiotic and antivirulence properties (5-FU), efficacy against multidrug resistant strains (Ga), and the ability to kill metabolically dormant persister cells which cause chronic infections (mitomycin C).


Asunto(s)
Antibacterianos/farmacología , Antineoplásicos/farmacología , Bacterias/efectos de los fármacos , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/microbiología , Reposicionamiento de Medicamentos , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Antibacterianos/química , Antibacterianos/uso terapéutico , Antineoplásicos/química , Antineoplásicos/uso terapéutico , Humanos , Pruebas de Sensibilidad Microbiana , Estructura Molecular
7.
Arch Med Res ; 44(7): 488-94, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24126126

RESUMEN

BACKGROUND AND AIMS: Quorum sensing (QS) is a process of bacterial cell-cell communication that controls a large number of systems affecting pathogenicity. Interrupting this communication system can provide nonvirulent pathogenic bacteria. The aim of this study was to evaluate the anti-quorum sensing (anti-QS) potential of an anacardic acids mixture isolated from Amphipterygium adstringens, a medicinal plant known as "cuachalalate", to prevent the onset of bacterial infections as an alternate to antibiotics. METHODS: Initially we investigated the anti-QS activity of A. adstringens hexane extract (HE) by the inhibition of violacein production in Chromobacterium violaceum. From the active HE, an anacardic acid mixture (AAM) was obtained. The anti-quorum sensing activity of AAM was investigated by the rhamnolipid and pyocyanin production constraint as well as decrease of elastase activity, all being quorum sensing-controlled virulence factors expressed in the pathogenic bacteria Pseudomonas aeruginosa. RESULTS: HE induced a 91.6% of inhibition of the violecin production at 55 µg/mL concentration, whereas AAM showed 94% of inhibition at 166 µg/mL. In both cases, inhibition of violacein production did not affect the viability of the bacterium. AAM inhibited pyocyanin (86% at 200 µg/mL) and rhamnolipid (91% at 500 µg/mL) production in a dose/response form and decrease the elastase (75% at 500 µg/mL) activity in P. aeruginosa without affecting its development. CONCLUSIONS: Because an anacardic acids mixture isolated from A. adstringens demonstrated anti-QS, it could be further exploited for novel molecules to treat the emerging infections of antibiotic-resistant bacterial pathogens.


Asunto(s)
Ácidos Anacárdicos/farmacología , Chromobacterium/efectos de los fármacos , Pseudomonas aeruginosa/efectos de los fármacos , Percepción de Quorum/efectos de los fármacos , Factores de Virulencia/antagonistas & inhibidores , Anacardiaceae/química , Ácidos Anacárdicos/aislamiento & purificación , Animales , Antibacterianos/farmacología , Chromobacterium/crecimiento & desarrollo , Chromobacterium/patogenicidad , Farmacorresistencia Bacteriana , Glucolípidos/antagonistas & inhibidores , Glucolípidos/metabolismo , Indoles/antagonistas & inhibidores , Indoles/metabolismo , Masculino , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/aislamiento & purificación , Extractos Vegetales/farmacología , Pseudomonas aeruginosa/crecimiento & desarrollo , Pseudomonas aeruginosa/patogenicidad , Piocianina/antagonistas & inhibidores , Piocianina/metabolismo , Factores de Virulencia/metabolismo
8.
Nat Prod Res ; 25(13): 1282-7, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21815722

RESUMEN

A new anacardic acid, 6-[16'Z-nonadecenyl]-salicylic acid (1), along with seven known compounds, 6-[8'Z-pentadecenyl] salicylic acid (15:1 anacardic acid) (2), 6-nonadecenyl salicylic acid (anacardic acid 19:0) (3), 6-pentadecyl salicylic acid (anacardic acid 15:0) (4), masticadienonic acid (5), 3α-hydroxymasticadienonic acid (6), 3-epi-oleanolic acid (7) and ß-sitosterol, were isolated from the bark of Amphipterygium adstringens using a bioassay-guided fractionation method. The structure of the new compound (1) was elucidated by spectroscopic data interpretation. The known compounds (2-7) were identified by comparison of their spectroscopic data with reported values in the literature. Compounds 1-4 exhibited antibacterial activity against Streptococcus mutans and Porphyromonas gingivalis with minimum inhibitory concentrations ranging from 7 to 104 µg mL and from 12 to 126 µg mL, respectively.


Asunto(s)
Ácidos Anacárdicos/aislamiento & purificación , Ácidos Anacárdicos/farmacología , Antibacterianos/aislamiento & purificación , Antibacterianos/farmacología , Porphyromonas gingivalis/efectos de los fármacos , Streptococcus mutans/efectos de los fármacos , Ácidos Anacárdicos/química , Antibacterianos/química , Evaluación Preclínica de Medicamentos , Espectroscopía de Resonancia Magnética
9.
J Ethnopharmacol ; 122(2): 402-5, 2009 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-19162157

RESUMEN

AIM OF THE STUDY: Helicobacter pylori is the major etiological agent of chronic active gastritis and peptic ulcer disease and is linked to gastric carcinoma. Treatment to eradicate the bacteria failed in many cases, mainly due to antibiotic resistance, hence the necessity of developing better therapeutic regimens. Mexico has an enormous unexplored potential of medicinal plants. This work evaluates the in vitro anti-H. pylori activity of 53 plants used in Mexican traditional medicine for gastrointestinal disorders. MATERIALS AND METHODS: To test the in vitro antibacterial activity, agar dilution and broth dilution methods were used for aqueous and methanolic extracts, respectively. RESULTS: Aqueous extracts of Artemisia ludoviciana subsp. mexicana, Cuphea aequipetala, Ludwigia repens,and Mentha x piperita (MIC 125 to <250 microg/ml) as well as methanolic extracts of Persea americana, Annona cherimola, Guaiacum coulteri, and Moussonia deppeana (MIC <7.5 to 15.6 microg/ml) showed the highest inhibitory effect. CONCLUSIONS: The results contribute to understanding the mode of action of the studied medicinal plants and for detecting plants with high anti-Helicobacter pylori activity.


Asunto(s)
Antibacterianos/farmacología , Enfermedades Gastrointestinales/microbiología , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Magnoliopsida , Medicina Tradicional , Extractos Vegetales/farmacología , Plantas Medicinales , Animales , Antibacterianos/uso terapéutico , Enfermedades Gastrointestinales/tratamiento farmacológico , México , Pruebas de Sensibilidad Microbiana , Fitoterapia , Extractos Vegetales/uso terapéutico
10.
J Ethnopharmacol ; 114(1): 72-7, 2007 Oct 08.
Artículo en Inglés | MEDLINE | ID: mdl-17768020

RESUMEN

Amphipterygium adstringens (Schltdl.) Standl. (Anacardiaceae) is widely used in traditional Mexican medicine for the treatment of gastritis and ulcers. In this work, we studied the anti-Helicobacter pylori activity of its bark, this Gram-negative bacterium is considered the major etiological agent of chronic active gastritis and peptic ulcer disease, and it is linked to gastric carcinoma. From a bio-guided assay of the fractions obtained form a continuous Soxhlet extraction of the bark, we identified that petroleum ether fraction had significant antimicrobial activity against Helicobacter pylori. From this fraction, we isolated an anacardic acids mixture and three known triterpenes: masticadienonic acid; 3alpha-hydroxymasticadienonic acid; 3-epi-oleanolic; as well as the sterol beta-sitosterol. Only the anacardic acids mixture exhibits a potent dose-dependent antibacterial activity (MIC=10 microg/ml in broth cultures). It is enriched in saturated alkyl phenolic acids (C15:0, C16:0, C17:0 C19:0) which represents a novel source of these compounds with potent anti-Helicobacter pylori activity. The promising use of anacardic acids and Amphipterygium adstringens bark in the development of an integral treatment of Helicobacter pylori diseases is discussed.


Asunto(s)
Anacardiaceae/química , Ácidos Anacárdicos/farmacología , Antibacterianos/farmacología , Helicobacter pylori/efectos de los fármacos , Extractos Vegetales/farmacología , Ácidos Anacárdicos/administración & dosificación , Ácidos Anacárdicos/aislamiento & purificación , Antibacterianos/administración & dosificación , Antibacterianos/aislamiento & purificación , Relación Dosis-Respuesta a Droga , Humanos , Hidroxibenzoatos/administración & dosificación , Hidroxibenzoatos/aislamiento & purificación , Hidroxibenzoatos/farmacología , Medicina Tradicional , México , Pruebas de Sensibilidad Microbiana , Ácido Oleanólico/aislamiento & purificación , Ácido Oleanólico/farmacología , Corteza de la Planta , Extractos Vegetales/administración & dosificación , Extractos Vegetales/aislamiento & purificación , Sitoesteroles/aislamiento & purificación , Sitoesteroles/farmacología , Triterpenos/aislamiento & purificación , Triterpenos/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA